ti

dtyp2SF 22634002,22634002,22032720,22526518,22341087,22526518,22810370,23514705,23299310,23707808,23266888,22926062,23011589,22215137,23248262,23269246,23125418,23564603,18946352,22350746,20631881,23278273,21287554,17603493,22237629,23817426,22450806,22474024,21376641,21734236,21728175,21797940,21949025,2110319,22179405,23824734,23372655,22899991,22039302,23850964,20517723,20530204,19681826,20348242,17257744,18790673,18828017,19336265,7641218,20028852,21068404,23382560,21795591,23757729,22810370,22526518,20032720,22469976,23222714,21262283,19882154,23018462,18802069,18809714,23277486,21483776,20574007,21697013,23180822,22634002,23514705,17483367,23369567,20587738,21972293,22025564,19265159,23897167,23477736,23064360,21507122,22696261,22132131,21697282,19155514,21900179,19351842,21426948,23757323,23045614,20652350,23576079,22864396,[PMID]

To obtain Papers by PMID numbers, use www.moremed.org
Your Search was translated by PubMed to 22634002,22634002,22032720,22526518,22341087,22526518,22810370,23514705,23299310,23707808,23266888,22926062,23011589,22215137,23248262,23269246,23125418,23564603,18946352,22350746,20631881,23278273,21287554,17603493,22237629,23817426,22450806,22474024,21376641,21734236,21728175,21797940,21949025,2110319,22179405,23824734,23372655,22899991,22039302,23850964,20517723,20530204,19681826,20348242,17257744,18790673,18828017,19336265,7641218,20028852,21068404,23382560,21795591,23757729,22810370,22526518,20032720,22469976,23222714,21262283,19882154,23018462,18802069,18809714,23277486,21483776,20574007,21697013,23180822,22634002,23514705,17483367,23369567,20587738,21972293,22025564,19265159,23897167,23477736,23064360,21507122,22696261,22132131,21697282,19155514,21900179,19351842,21426948,23757323,23045614,20652350,23576079,22864396[UID]

Shown are free items 1 to 57 of 57

Shown are unfree items 1 to 29 of 29

22634002, 22634002, 22032720, 22526518, 22341087, 22526518, 22810370, 23514705, 23299310, 23707808, 23266888, 22926062, 23011589, 22215137, 23248262, 23269246, 23125418, 23564603, 18946352, 22350746, 20631881, 23278273, 21287554, 17603493, 22237629, 23817426, 22450806, 22474024, 21376641, 21734236, 21728175, 21797940, 21949025, 2110319, 22179405, 23824734, 23372655, 22899991, 22039302, 23850964, 20517723, 20530204, 19681826, 20348242, 17257744, 18790673, 18828017, 19336265, 7641218, 20028852, 21068404, 23382560, 21795591, 23757729, 22810370, 22526518, 20032720, 22469976, 23222714, 21262283, 19882154, 23018462, 18802069, 18809714, 23277486, 21483776, 20574007, 21697013, 23180822, 22634002, 23514705, 17483367, 23369567, 20587738, 21972293, 22025564, 19265159, 23897167, 23477736, 23064360, 21507122, 22696261, 22132131, 21697282, 19155514, 21900179, 19351842, 21426948, 23757323, 23045614, 20652350, 23576079, 22864396, [PMID]

Free papers
PMC3688892 1. Resistance to Streptozotocin-Induced Autoimmune Diabetes in Absence of Complement C3: Myeloid-Derived Suppressor Cells Play a Role. PLoS One 2013; 8 (6): e66334		23824734 23824734
PMC3744987 2. Fibrocytes represent a novel MDSC subset circulating in patients with metastatic cancer. Blood 2013; 122 (7): 1105-13		23757729 23757729
PMC8639200 3. microRNAs as potential regulators of myeloid-derived suppressor cell expansion. Innate Immun 2014; 20 (3): 227-38		23757323 23757323
PMC3785672 4. Pancreatic cancer-associated stellate cells promote differentiation of myeloid-derived suppressor cells in a STAT3-dependent manner. Cancer Res 2013; 73 (10): 3007-18		23514705 23514705
5. Tumor necrosis factor-alpha blocks differentiation and enhances suppressive activity of immature myeloid cells during chronic inflammation. Immunity 2013; 38 (3): 541-54		23477736 23477736
PMC3586977 6. In vivo ablation of plasmacytoid dendritic cells inhibits autoimmunity through expansion of myeloid-derived suppressor cells. J Immunol 2013; 190 (6): 2631-40		23382560 23382560
PMC3556079 7. Inhibition of IL-17A in tumor microenvironment augments cytotoxicity of tumor-infiltrating lymphocytes in tumor-bearing mice. PLoS One 2013; 8 (1): e53131		23372655 23372655
PMC3560989 8. Generation of myeloid-derived suppressor cells using prostaglandin E2. Transplant Res 2012; 1 (1): 15		23369567 23369567
PMC3591797 9. The role of complement component 3 (C3) in differentiation of myeloid-derived suppressor cells. Blood 2013; 121 (10): 1760-8		23299310 23299310
10. Ly6C+ Ly6G- Myeloid-derived suppressor cells play a critical role in the resolution of acute inflammation and the subsequent tissue repair process after spinal cord injury. J Neurochem 2013; 125 (1): 74-88		23278273 23278273
PMC4044918 11. The receptor for advanced glycation end products promotes pancreatic carcinogenesis and accumulation of myeloid-derived suppressor cells. J Immunol 2013; 190 (3): 1372-9		23269246 23269246
PMC3587709 12. A novel role of hematopoietic CCL5 in promoting triple-negative mammary tumor progression by regulating generation of myeloid-derived suppressor cells. Cell Res 2013; 23 (3): 394-408		23266888 23266888
PMC3529820 13. TIM-3 regulates innate immune cells to induce fetomaternal tolerance. J Immunol 2013; 190 (1): 88-96		23180822 23180822
PMC3518629 14. Macrophage migration inhibitory factor promotes tumor growth and metastasis by inducing myeloid-derived suppressor cells in the tumor microenvironment. J Immunol 2012; 189 (12): 5533-40		23125418 23125418
PMC3484453 15. TNF signaling drives myeloid-derived suppressor cell accumulation. J Clin Invest 2012; 122 (11): 4094-104		23064360 23064360
PMC3531993 16. Depletion of plasmacytoid dendritic cells inhibits tumor growth and prevents bone metastasis of breast cancer cells. J Immunol 2012; 189 (9): 4258-65		23018462 23018462
PMC3543472 17. Low-dose cyclophosphamide administered as daily or single dose enhances the antitumor effects of a therapeutic HPV vaccine. Cancer Immunol Immunother 2013; 62 (1): 171-82		23011589 23011589
PMC3416819 18. Structurally modified curcumin analogs inhibit STAT3 phosphorylation and promote apoptosis of human renal cell carcinoma and melanoma cell lines. PLoS One 2012; 7 (8): e40724		22899991 22899991
PMC3873637 19. Rosiglitazone and Gemcitabine in combination reduces immune suppression and modulates T cell populations in pancreatic cancer. Cancer Immunol Immunother 2013; 62 (2): 225-36		22864396 22864396
PMC4324169 20. MDSC: a new player in HIV immunopathogenesis. AIDS 2012; 26 (12): 1567-9		22810370 22810370
21. Two SHIPs passing in the middle of the immune system. Eur J Immunol 2012; 42 (7): 1681-4		22696261 22696261
22. Chronic progressive HIV-1 infection is associated with elevated levels of myeloid-derived suppressor cells. AIDS 2012; 26 (12): F31-7		22526518 22526518
PMC3887710 23. CD99-dependent expansion of myeloid-derived suppressor cells and attenuation of graft-versus-host disease. Mol Cells 2012; 33 (3): 259-67		22350746 22350746
PMC4062074 24. Antigen-specific CD4(+) T cells regulate function of myeloid-derived suppressor cells in cancer via retrograde MHC class II signaling. Cancer Res 2012; 72 (4): 928-38		22237629 22237629
PMC3697836 25. Pancreatic adenocarcinoma induces bone marrow mobilization of myeloid-derived suppressor cells which promote primary tumor growth. Cancer Immunol Immunother 2012; 61 (9): 1373-85		22215137 22215137
PMC3267010 26. Myeloid-derived suppressor cells protect islet transplants by B7-H1 mediated enhancement of T regulatory cells. Transplantation 2012; 93 (3): 272-82		22179405 22179405
PMC3222660 27. Murine pancreatic adenocarcinoma dampens SHIP-1 expression and alters MDSC homeostasis and function. PLoS One 2011; 6 (11): e27729		22132131 22132131
PMC3221925 28. Adenosinergic regulation of the expansion and immunosuppressive activity of CD11b+Gr1+ cells. J Immunol 2011; 187 (11): 6120-9		22039302 22039302
PMC4993027 29. PGE(2)-induced CXCL12 production and CXCR4 expression controls the accumulation of human MDSCs in ovarian cancer environment. Cancer Res 2011; 71 (24): 7463-70		22025564 22025564
PMC3217352 30. Positive feedback between PGE2 and COX2 redirects the differentiation of human dendritic cells toward stable myeloid-derived suppressor cells. Blood 2011; 118 (20): 5498-505		21972293 21972293
PMC3197898 31. IL-33 expands suppressive CD11b+ Gr-1(int) and regulatory T cells, including ST2L+ Foxp3+ cells, and mediates regulatory T cell-dependent promotion of cardiac allograft survival. J Immunol 2011; 187 (9): 4598-610		21949025 21949025
PMC3178672 32. Myeloid-specific expression of human lysosomal acid lipase corrects malformation and malfunction of myeloid-derived suppressor cells in lal-/- mice. J Immunol 2011; 187 (7): 3854-66		21900179 21900179
33. Interleukin-33 prolongs allograft survival during chronic cardiac rejection. Transpl Int 2011; 24 (10): 1027-39		21797940 21797940
PMC3159723 34. Phagocytosis, a potential mechanism for myeloid-derived suppressor cell regulation of CD8+ T cell function mediated through programmed cell death-1 and programmed cell death-1 ligand interaction. J Immunol 2011; 187 (5): 2291-301		21795591 21795591
PMC3709641 35. A human promyelocytic-like population is responsible for the immune suppression mediated by myeloid-derived suppressor cells. Blood 2011; 118 (8): 2254-65		21734236 21734236
36. Delayed type hypersensitivity-induced myeloid-derived suppressor cells regulate autoreactive T cells. Eur J Immunol 2011; 41 (10): 2871-82		21728175 21728175
PMC3156382 37. Api6/AIM/Spalpha/CD5L overexpression in alveolar type II epithelial cells induces spontaneous lung adenocarcinoma. Cancer Res 2011; 71 (16): 5488-99		21697282 21697282
PMC3164311 38. Emerging Tim-3 functions in antimicrobial and tumor immunity. Trends Immunol 2011; 32 (8): 345-9		21697013 21697013
PMC8094047 39. Myeloid-derived suppressor cells limit the inflammation by promoting T lymphocyte apoptosis in the spinal cord of a murine model of multiple sclerosis. Brain Pathol 2011; 21 (6): 678-91		21507122 21507122
PMC3069975 40. Role of myeloid-derived suppressor cells in amelioration of experimental autoimmune hepatitis following activation of TRPV1 receptors by cannabidiol. PLoS One 2011; 6 (4): e18281		21483776 21483776
PMC3119497 41. Hematopoietic cytokine-induced transcriptional regulation and Notch signaling as modulators of MDSC expansion. Int Immunopharmacol 2011; 11 (7): 808-15		21426948 21426948
PMC3064726 42. Paired immunoglobin-like receptor-B regulates the suppressive function and fate of myeloid-derived suppressor cells. Immunity 2011; 34 (3): 385-95		21376641 21376641
PMC3089902 43. In vivo suppressive function of myeloid-derived suppressor cells is limited to the inflammatory site. Eur J Immunol 2011; 41 (3): 749-59		21287554 21287554
PMC2902672 44. Agonistic Anti-CD137 Monoclonal Antibody Treatment Induces CD11bGr-1 Myeloid-derived Suppressor Cells. Immune Netw 2010; 10 (3): 104-8		20631881 20631881
PMC8454925 45. Pivotal Advance: Tumor-mediated induction of myeloid-derived suppressor cells and M2-polarized macrophages by altering intracellular PGE(2) catabolism in myeloid cells. J Leukoc Biol 2010; 88 (5): 839-48		20587738 20587738
PMC2925247 46. Tim-3/galectin-9 pathway: regulation of Th1 immunity through promotion of CD11b+Ly-6G+ myeloid cells. J Immunol 2010; 185 (3): 1383-92		20574007 20574007
PMC2901069 47. Hepatic acute-phase proteins control innate immune responses during infection by promoting myeloid-derived suppressor cell function. J Exp Med 2010; 207 (7): 1453-64		20530204 20530204
PMC3244828 48. STAT3: a target to enhance antitumor immune response. Curr Top Microbiol Immunol 2011; 344 (?): 41-59		20517723 20517723
PMC2861113 49. Contribution of MyD88 to the tumor exosome-mediated induction of myeloid derived suppressor cells. Am J Pathol 2010; 176 (5): 2490-9		20348242 20348242
PMC2805057 50. Myeloid-derived suppressor cells inhibit T-cell activation by depleting cystine and cysteine. Cancer Res 2010; 70 (1): 68-77		20028852 20028852
51. Endotoxin-induced myeloid-derived suppressor cells inhibit alloimmune responses via heme oxygenase-1. Am J Transplant 2009; 9 (9): 2034-47		19681826 19681826
PMC2705196 52. Lack of Muc1-regulated beta-catenin stability results in aberrant expansion of CD11b+Gr1+ myeloid-derived suppressor cells from the bone marrow. Cancer Res 2009; 69 (8): 3554-62		19351842 19351842
PMC2630116 53. Myeloid-specific expression of Api6/AIM/Sp alpha induces systemic inflammation and adenocarcinoma in the lung. J Immunol 2009; 182 (3): 1648-59		19155514 19155514
PMC2668611 54. Human inhibitory receptor immunoglobulin-like transcript 2 amplifies CD11b+Gr1+ myeloid-derived suppressor cells that promote long-term survival of allografts. Transplantation 2008; 86 (8): 1125-34		18946352 18946352
PMC2556797 55. Inhibition of dendritic cell differentiation and accumulation of myeloid-derived suppressor cells in cancer is regulated by S100A9 protein. J Exp Med 2008; 205 (10): 2235-49		18809714 18809714
PMC2810501 56. Proinflammatory S100 proteins regulate the accumulation of myeloid-derived suppressor cells. J Immunol 2008; 181 (7): 4666-75		18802069 18802069
PMC2135607 57. Altered recognition of antigen is a mechanism of CD8+ T cell tolerance in cancer. Nat Med 2007; 13 (7): 828-35		17603493 17603493
58. SSAO inhibitors suppress hepatocellular tumor growth in mice. Cell Immunol 2013; 283 (1-2): 61-9		23850964 23850964
59. Tumor-derived lactate modifies antitumor immune response: effect on myeloid-derived suppressor cells and NK cells. J Immunol 2013; 191 (3): 1486-95		23817426 23817426
60. HMGB1 recruits myeloid derived suppressor cells to promote peritoneal dissemination of colon cancer after resection. Biochem Biophys Res Commun 2013; 436 (2): 156-61		23707808 23707808
61. Intraoperative molecular analysis of total tumor load in sentinel lymph node: a new predictor of axillary status in early breast cancer patients. Breast Cancer Res Treat 2013; 139 (1): 87-93		23576079 23576079
62. IL-25 prevents and cures fulminant hepatitis in mice through a myeloid-derived suppressor cell-dependent mechanism. Hepatology 2013; 58 (4): 1436-50		23564603 23564603
63. Flagellin induces myeloid-derived suppressor cells: implications for Pseudomonas aeruginosa infection in cystic fibrosis lung disease. J Immunol 2013; 190 (3): 1276-84		23277486 23277486
64. Increased myeloid-derived suppressor cells in gastric cancer correlate with cancer stage and plasma S100A8/A9 proinflammatory proteins. J Immunol 2013; 190 (2): 794-804		23248262 23248262
65. Role of OGR1 in myeloid-derived cells in prostate cancer. Oncogene 2014; 33 (2): 157-64		23222714 23222714
66. Smad3-deficient CD11b(+)Gr1(+) myeloid-derived suppressor cells prevent allograft rejection via the nitric oxide pathway. J Immunol 2012; 189 (10): 4989-5000		23045614 23045614
PMC11029128 67. Metronomic chemotherapy with low-dose cyclophosphamide plus gemcitabine can induce anti-tumor T cell immunity in vivo. Cancer Immunol Immunother 2013; 62 (2): 383-91		22926062 22926062
68. The role of myofibroblasts in upregulation of S100A8 and S100A9 and the differentiation of myeloid cells in the colorectal cancer microenvironment. Biochem Biophys Res Commun 2012; 423 (1): 60-6		22634002 22634002
69. Functional changes in myeloid-derived suppressor cells (MDSCs) during tumor growth: FKBP51 contributes to the regulation of the immunosuppressive function of MDSCs. J Immunol 2012; 188 (9): 4226-34		22474024 22474024
70. Host-related carcinoembryonic antigen cell adhesion molecule 1 promotes metastasis of colorectal cancer. Oncogene 2013; 32 (7): 849-60		22469976 22469976
71. Control of transplant tolerance and intragraft regulatory T cell localization by myeloid-derived suppressor cells and CCL5. J Immunol 2012; 188 (9): 4209-16		22450806 22450806
72. G-CSF stem cell mobilization in human donors induces polymorphonuclear and mononuclear myeloid-derived suppressor cells. Clin Immunol 2012; 143 (1): 83-7		22341087 22341087
73. Castleman disease in a pediatric liver transplant recipient: a case report and literature review. Pediatr Transplant 2012; 16 (6): E229-34		22032720 22032720
74. Myeloid-derived suppressor cells exhibit two bioenergetic steady-states in vitro. J Biotechnol 2011; 152 (1-2): 43-8		21262283 21262283
75. Depletion of regulatory T cells facilitates growth of established tumors: a mechanism involving the regulation of myeloid-derived suppressor cells by lipoxin A4. J Immunol 2010; 185 (12): 7199-206		21068404 21068404
76. Involvement of CD11b+ GR-1 low cells in autoimmune disorder in MRL-Fas lpr mouse. Clin Exp Nephrol 2010; 14 (5): 411-7		20652350 20652350
77. Stat 6-dependent induction of myeloid derived suppressor cells after physical injury regulates nitric oxide response to endotoxin. Ann Surg 2010; 251 (1): 120-6		20032720 20032720
PMC11030737 78. Generation of antigen-presenting cells from tumor-infiltrated CD11b myeloid cells with DNA demethylating agent 5-aza-2'-deoxycytidine. Cancer Immunol Immunother 2010; 59 (5): 697-706		19882154 19882154
79. Gemcitabine directly inhibits myeloid derived suppressor cells in BALB/c mice bearing 4T1 mammary carcinoma and augments expansion of T cells from tumor-bearing mice. Int Immunopharmacol 2009; 9 (7-8): 900-9		19336265 19336265
80. Fas signal promotes lung cancer growth by recruiting myeloid-derived suppressor cells via cancer cell-derived PGE2. J Immunol 2009; 182 (6): 3801-8		19265159 19265159
PMC11030939 81. Regulation of arginase I activity and expression by both PD-1 and CTLA-4 on the myeloid-derived suppressor cells. Cancer Immunol Immunother 2009; 58 (5): 687-97		18828017 18828017
82. B7-H1 on myeloid-derived suppressor cells in immune suppression by a mouse model of ovarian cancer. Clin Immunol 2008; 129 (3): 471-81		18790673 18790673
83. Prostaglandin E2 promotes tumor progression by inducing myeloid-derived suppressor cells. Cancer Res 2007; 67 (9): 4507-13		17483367 17483367
84. CCL2/CCR2 pathway mediates recruitment of myeloid suppressor cells to cancers. Cancer Lett 2007; 252 (1): 86-92		17257744 17257744
PMC11037780 85. Treating tumor-bearing mice with vitamin D3 diminishes tumor-induced myelopoiesis and associated immunosuppression, and reduces tumor metastasis and recurrence. Cancer Immunol Immunother 1995; 41 (1): 37-45		7641218 7641218
86. Meeting the challenge of racism. Nurs Stand 1990; 4 (31): 54-5		2110319 2110319

The checkboxes will funnel the pmids of the checked items to a new window of multiple emerging functions. Do not check more than 100 records at one time. Press green button to proceed.